Molecular Docking for Drug Discovery: Virtual Screening Guide
Learn how molecular docking is used in drug discovery. Virtual screening, lead optimization, and free docking tools.
Last updated: September 2026
Quick Answer
Molecular docking predicts how a drug-like molecule binds to a protein target. It estimates the binding pose (orientation) and affinity (strength). In drug discovery, docking is used for virtual screening (testing millions of compounds computationally) and lead optimization (improving promising hits).
Use VigyanLLM's free docking tool to dock ligands against your protein target — powered by AutoDock Vina, no installation needed.
How Molecular Docking Works
Molecular docking simulates the interaction between a protein (the target) and a small molecule (the ligand). The process has three stages:
- Protein preparation — Remove water molecules, add hydrogen atoms, assign partial charges, and define the binding site (the pocket where the ligand will bind).
- Ligand preparation — Generate 3D coordinates, assign charges, and explore rotatable bonds. The ligand is a flexible molecule that needs multiple conformations sampled.
- Scoring and ranking — A scoring function estimates the binding free energy (kcal/mol) for each predicted pose. More negative values indicate stronger binding.
The Scoring Function: What the Numbers Mean
Scoring functions estimate how tightly a ligand binds to a protein. They combine terms for van der Waals interactions, electrostatics, hydrogen bonding, and desolvation energy. Common scoring functions include Vina (used in VigyanLLM), ChemScore, and GlideScore.
| Score (kcal/mol) | Interpretation | Action |
|---|---|---|
| -5 to -7 | Moderate binding | Possible hit; worth investigating |
| -7 to -9 | Good binding | Strong candidate for experimental validation |
| -9 to -12 | Very strong binding | High-priority hit; validate with IC50 |
| Better than -12 | Exceptional (rare) | Check for scoring artifacts; verify with MD simulation |
Virtual Screening in Drug Discovery
Virtual screening is the process of computationally evaluating millions of compounds against a protein target to identify potential drug candidates. Instead of testing every compound in the lab (which costs time and money), docking ranks them by predicted binding affinity.
High-Throughput Virtual Screening (HTVS) Pipeline
- Library preparation — Start with a chemical library (ZINC, ChEMBL, Enamine REAL). Filter for drug-like properties (Lipinski's Rule of Five: MW < 500, LogP < 5, HBD ≤ 5, HBA ≤ 10).
- Receptor preparation — Obtain a crystal structure from PDB (resolution < 2.5 Å). Remove water, add hydrogens, define the binding pocket using known ligands or cavity detection.
- Docking — Run each compound through the docking algorithm. For large libraries (1M+ compounds), use hierarchical screening: fast pre-filter, then accurate docking on survivors.
- Post-processing — Cluster top hits by chemical similarity. Visualize binding poses. Check for ADMET violations (absorption, distribution, metabolism, excretion, toxicity).
- Experimental validation — Purchase top 50-100 compounds. Test in biochemical assays (IC50, Ki) and cell-based assays.
Lead Optimization: From Hit to Drug Candidate
Virtual screening identifies hits — compounds with measurable activity. Lead optimization turns hits into drug candidates by improving potency, selectivity, and drug-like properties. Docking plays a central role in this process.
Structure-Activity Relationship (SAR) via Docking
After identifying a hit, medicinal chemists modify the molecule and re-dock to predict how changes affect binding. Common optimization strategies include:
- Functional group additions — Adding hydrogen bond donors/acceptors to fill binding pockets
- Bioisosteric replacement — Swapping chemical groups with similar properties to improve metabolic stability
- Rigidification — Constraining flexible bonds to reduce entropic penalty upon binding
- Selectivity screening — Docking against off-target proteins to predict and avoid side effects
Try Molecular Docking for Free
Upload your protein and ligand to VigyanLLM. Get binding pose predictions and affinity scores in minutes.
Start Docking Now →Protein Preparation Checklist
Before docking, your protein structure must be properly prepared. Incomplete preparation is the most common cause of poor docking results.
| Step | What to Do | Why |
|---|---|---|
| Download from PDB | Use resolution < 2.5 Å; check for missing residues | Low-resolution structures have unreliable coordinates |
| Remove water | Delete all water molecules except those in the active site | Water molecules not in the binding site add noise |
| Add hydrogens | Add all missing hydrogen atoms | Hydrogen bonds are critical for binding prediction |
| Assign charges | Add partial charges (Gasteiger or AM1-BCC) | Electrostatic interactions drive binding |
| Define binding site | Use known ligand position or cavity detection | The search space must cover the entire binding pocket |
| Minimize energy | Relax the structure with energy minimization | Removes steric clashes from crystal structure |
Limitations of Molecular Docking
- Scoring function accuracy — Approximate energy functions; false positives are common (30-50% of top hits may not bind experimentally)
- Protein flexibility — Most docking treats the protein as rigid; induced-fit effects are missed
- Solvation — Water molecules in the binding site are often ignored
- Entropy — Scoring functions underestimate entropic contributions to binding
- ADMET — Docking predicts binding, not absorption, metabolism, or toxicity
Best practice: use docking as a filtering step, not a final answer. Combine with molecular dynamics, ADMET prediction, and experimental validation.
Related Tools
- Molecular Docking Tool — free protein-ligand docking powered by AutoDock Vina
- Docking Score Interpretation — detailed guide to reading docking results
- Protein-Ligand Docking Guide — step-by-step protocol for docking experiments
Frequently Asked Questions
What is molecular docking in drug discovery?
Molecular docking is a computational method that predicts how a small molecule (ligand) binds to a protein target. It estimates the binding pose (orientation) and binding affinity (strength) of the interaction. In drug discovery, docking is used to screen millions of compounds virtually before testing them in the lab.
How does virtual screening work?
Virtual screening uses molecular docking to evaluate a large library of compounds against a protein target. Each compound is docked into the binding site, scored for binding affinity, and ranked. The top-scoring compounds are then tested experimentally. This narrows millions of candidates to hundreds for wet-lab validation.
What is a good docking score?
Docking scores are reported in kcal/mol (binding free energy). More negative values indicate stronger binding. A score below -7 kcal/mol is generally considered a good hit. Below -9 kcal/mol is very strong. However, scores are approximate and should always be validated with experimental assays like IC50 or Ki measurements.
What are the limitations of molecular docking?
Docking has several limitations: scoring functions are approximate, protein flexibility is often ignored, solvation effects are simplified, and false positives are common. Best practice is to use docking as a filtering step, not a final answer. Combine with ADMET prediction, molecular dynamics, and experimental validation.
Can I use VigyanLLM for molecular docking?
Yes. VigyanLLM offers free protein-ligand docking powered by AutoDock Vina. Upload your protein structure and ligand, and the tool predicts the binding pose and affinity. It supports single-ligand docking and is designed for researchers who need quick, reliable docking results without installing local software.